Applications of Site-Specific Recombination As Can Be Seen from the Examples Discussed Above, the Same Mechanism of DNA Recombin

Total Page:16

File Type:pdf, Size:1020Kb

Applications of Site-Specific Recombination As Can Be Seen from the Examples Discussed Above, the Same Mechanism of DNA Recombin Applications of site-specific recombination As can be seen from the examples discussed above, the same mechanism of DNA recombination can be utilized in different biological contexts to bring about integration, excision (deletion) and inversion of DNA segments. In principle, then, one should be able to adapt site-specific recombination systems to direct one or more of these types of DNA rearrangements in selected regions of a genome of interest. This expectation has been fully validated. Site-specific recombination has been utilized in promoting genetic alterations for answering fundamental questions in biology and for developing biotechnological tools. Since Cre and Flp have extremely simple reaction requirements, these recombination systems have been reconstituted in a variety of organisms-bacteria, fungi, plants, nematodes, flies and animals. Cre and Flp can be placed under regulatable promoters for conditional or tissue- specific expression. An important first step in applying site-specific recombination in a genetic context of interest is the introduction of the target site or sites at the desired locale(s). Once this has been accomplished, the rest of the experimental steps are quite straightforward. Tracking cell lineage during development One of the most useful applications of site-specific recombination in basic biology has been in tracking the lineage of cells during development. The early work was done in Drosophila using the Flp-FRT system. The method has been extended to a variety of developmental systems, helped, in particular, by important technological advances in fluorescence microscopy and the development of multi-color reporter constructs. The principle of the method is illustrated in the figure below. Here site-specific recombination is used to bring about mitotic recombination between homologous chromosomes. In an organism such as Drosophila, the reporter constructs and the recombination sites can be appropriately placed in the chromosomes to be manipulated. The FRT sites are placed at identical positions close to the centromeres of a pair of homologous chromosomes. In one chromosome a GFP (green fluorescent protein) reporter gene, lacking a promoter, is placed adjacent to the FRT site as shown in the figure below. In the homologue, a promoter sequence is placed next to the FRT site. At a certain stage in development, as demanded by the experimental objective, the Flp protein is expressed by turning on a conditional promoter that controls the FLP gene. Consider the state of a cell in which DNA replication has been completed. There are two sister copies of each of the two chromosomes that we are interested in. Each pair of sister chromatids is held together, so that they can be segregated to the daughter cells in a one-to-one fashion. When recombination occurs between FRT sites as diagrammed, one chromosome acquires the promoter from its partner, and becomes competent to express GFP. When the cell divides, only one of the two daughter cells will acquire this chromosome; therefore only this cell will express GFP, and appear as green under the fluorescence microscope. The other will lack fluorescence. All the cells resulting from the division of the fluorescent progenitor cell will also be green. These clones will form a mosaic against the majority of cells that are non-fluorescent. Thus, by tracking fluorescence, cell lineage can be followed during development. Ablating a gene function during development One can also delete a particular gene at a given stage of development, and follow the consequence of the deletion during further development. Here the locus of interest is flanked by two copies of FRT in a direct (or headͲtoͲtai) orientation (see the figure above). The Flp protein is induced from a regulated promoter. If one expresses the Flp gene from a tissue specific promoter, the deletion will occur only in that particular tissue. The effects of removing the gene function in a given tissue or a set of tissues can be followed. Inducing the expression of a gene at a specific time in development One can induce the expression of a gene at a desired point in development via site-specific recombination. For example, imagine a gene X engineered in such a way that its promoter is oriented in the nonͲfunctional direction (see the figure below). The promoter is flanked by two FRT sites in the direct or headͲtoͲhead orientation. When the Flp protein is induced at the appropriate time, recombination by Flp will invert the DNA segment containing the promoter. It is now turned around, and acquires the functional orientation, thus turning on the gene X. + Alternatively, one can introduce a transcription terminator site between the promoter and the gene of interest (see the figure below). The terminator is flanked by a recombination target site at either end, with the sites arranged as direct repeats. With the terminator present, transcription initiated at the promoter cannot get past the terminator and enter the gene. However, when the terminator is removed by recombination, transcription proceeds into the gene, thus activating its function. Site-specific recombination in biotechnological applications Once the target site has been inserted into the genomic locus of interest, one can perform integration of an exogenous DNA sequence into this target site. Since the inserted sequence is flanked by two directly repeated (head-to-tail) target sites, it can also be excised from the genome by recombination. These operations can be performed in a regulated fashion by inducible expression of the recombinase. Similarly, if two target sites are inserted on either side of a certain genetic locus, recombination can be used to excise the locus. Removal of integrated harmful viral sequences would be a potential beneficial application of site-specific recombination. A more recent application of site specific recombination in biotechnology is described as recombination mediated cassette exchange (RMCE; see Figure below). This method uses two recombination events to replace the endogenous chromosomal locus by a new one. Originally, a single recombinase was used for RMCE (shown in A). RTa and RTa* are slightly altered sites, so that Rta x Rta* recombination cannot occur. However, the recombinase can act on both RTa and RTa* with nearly equal efficiencies. [I shall explain in class how this can be done.] In later versions of RMCE, two recombinases and their respective target sites were employed. The two cross-over events diagrammed cleanly splices out the pre-existing locus, and exchanges it for the incoming locus. Expanding the utility of site-specific recombination in biotechnology As we already saw, one of the limitations in the application of site-specific recombination in biotechnology is the introduction of the target site being a pre-requisite for manipulating a genome of interest. The other is the small number of recombinases that can be easily manipulated for genome engineering purposes. For all practical purposes, the number is two, Cre and Flp. For each recombinase, one can generate a small set of variant target sites that are not cross reactive with each other, but are normal or nearly normal in self-reactions. These target sites are created by changing the sequence of the short strand exchange region without changing the binding sites for the recombinase. The absolute sequence of the strand exchange region is not terribly important for recombination (although some sequences work poorly). However, there has to be perfect homology between the strand exchange regions for recombination to occur between two target sites. In other words, an altered site is reactive with a second copy of itself, but non-reactive with the native site or with another altered site containing a different substitution. A potentially useful approach to expand the utility of site-specific recombination is to generate recombinases with altered binding (DNA recognition) specificities. That is, change the sequence of the binding elements, and then produce active recombinase variants that have acquired the corresponding new recognition capabilities. Although this idea would seem reasonably straightforward, this is quite difficult to accomplish in practice. Note that the present day Flp or Cre represent the optimization of DNA-protein recognition and catalysis over evolutionary time. It would be quite difficult to redesign that optimization within the time frame of laboratory experiments. Nevertheless, what one tries to do is mimic the process evolution in the test tube. The approach is called directed in vitro evolution, and is briefly described below. On can generate a large pool of random mutants of the recombinase gene, preferably by PCR- based mutagenesis. Among the 107 or 108 of mutants generated, there might be one or a tiny number of recombinase variants that might have acquired specificity for the new target sequence that we designed. The predominant majority will consist of recombinases that have lost function because of acquired mutations or have not changed their DNA recognition. These are not of interest to us. The problem is how to find the needle in the hay stack. For this one has to have a simple and quick genetic or physical screens to track down the clones of interest to us. The way the directed evolution protocol is carried out is as follows. First, we transform the mutant library into an E. coli host, and collect the transformants, say, 107 independent transformants. To screen just one equivalent of this library by standard genetic assays, one would require about 104 large petri dishes (about 1000-1500 colonies can be plated out on a dish without overcrowding). Many times more colonies can be analyzed by physical screen using fluorescence reporters and high throughput cell sorting machines. 109 cells can be sorted in several hours using state of the art sorters. Changing the target specificity of Flp Here is one example of a genetic screen. We want to identify Flp variants with their specificity shifted away from the native FRT site and towards a mutant FRT site, called mFRT.
Recommended publications
  • P1 Bacteriophage and Tol System Mutants
    P1 BACTERIOPHAGE AND TOL SYSTEM MUTANTS Cari L. Smerk A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF SCIENCE August 2007 Committee: Ray A. Larsen, Advisor Tami C. Steveson Paul A. Moore Lee A. Meserve ii ABSTRACT Dr. Ray A. Larsen, Advisor The integrity of the outer membrane of Gram negative bacteria is dependent upon proteins of the Tol system, which transduce cytoplasmic-membrane derived energy to as yet unidentified outer membrane targets (Vianney et al., 1996). Mutations affecting the Tol system of Escherichia coli render the cells resistant to a bacteriophage called P1 by blocking the phage maturation process in some way. This does not involve outer membrane interactions, as a mutant in the energy transucer (TolA) retained wild type levels of phage sensitivity. Conversely, mutations affecting the energy harvesting complex component, TolQ, were resistant to lysis by bacteriophage P1. Further characterization of specific Tol system mutants suggested that phage maturation was not coupled to energy transduction, nor to infection of the cells by the phage. Quantification of the number of phage produced by strains lacking this protein also suggests that the maturation of P1 phage requires conditions influenced by TolQ. This study aims to identify the role that the TolQ protein plays in the phage maturation process. Strains of cells were inoculated with bacteriophage P1 and the resulting production by the phage of viable progeny were determined using one step growth curves (Ellis and Delbruck, 1938). Strains that were lacking the TolQ protein rendered P1 unable to produce the characteristic burst of progeny phage after a single generation of phage.
    [Show full text]
  • Scalable Recombinase-Based Gene Expression Cascades
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.161430; this version posted June 20, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title: Scalable recombinase-based gene expression cascades One Sentence Summary: Recombinase-based gene circuits enable scalable and sequential gene modulation. Authors: Tackhoon Kim1,2, Benjamin Weinberg3, Wilson Wong3, Timothy K. Lu1,* Affiliations: 1 Research Lab of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. 2 Chemical Kinomics Research Center, Korea Institute of Science and Technology, 5 Hwarangro 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea 3 Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA. *Correspondence to: [email protected] (T.K.L) Abstract: Temporal modulation of multiple genes underlies sophisticated biological phenomena. However, there are few scalable and generalizable gene circuit architectures for the programming of sequential genetic perturbations. We describe a modular recombinase-based gene circuit architecture, comprising tandem gene perturbation cassettes (GPCs), that enables the sequential expression of multiple genes in a defined temporal order by alternating treatment with just two orthogonal ligands. We used tandem GPCs to sequentially express single-guide RNAs to encode transcriptional cascades and trigger the sequential accumulation of mutations. We built an all-in- one gene circuit that sequentially edits genomic loci, synchronizes cells at a specific stage within bioRxiv preprint doi: https://doi.org/10.1101/2020.06.20.161430; this version posted June 20, 2020.
    [Show full text]
  • Identification and Analysis of Recombineering Functions from Gram-Negative and Gram-Positive Bacteria and Their Phages
    Identification and analysis of recombineering functions from Gram-negative and Gram-positive bacteria and their phages Simanti Datta, Nina Costantino, Xiaomei Zhou, and Donald L. Court† Gene Regulation and Chromosome Biology Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702 Edited by Sankar Adhya, National Institutes of Health, Bethesda, MD, and approved December 12, 2007 (received for review September 25, 2007) We report the identification and functional analysis of nine genes but linear DNA recombination studies with RecET have used ␭ from Gram-positive and Gram-negative bacteria and their phages Gam to inhibit nucleases (4). that are similar to lambda (␭) bet or Escherichia coli recT. Beta and For recombineering, either a dsDNA PCR product (1, 4, RecT are single-strand DNA annealing proteins, referred to here as 15–17) or an oligonucleotide (oligo) (18–21) carrying short recombinases. Each of the nine other genes when expressed in E. (Ϸ50-bp) segments homologous to the target sequences can be coli carries out oligonucleotide-mediated recombination. To our used. These linear DNA substrates are precisely recombined in knowledge, this is the first study showing single-strand recombi- vivo by the phage proteins to target DNA on any replicon. When nase activity from diverse bacteria. Similar to bet and recT, most of linear dsDNA is used for recombination, both the exonuclease these other recombinases were found to be associated with pu- and single-strand annealing protein are required. For optimal tative exonuclease genes. Beta and RecT in conjunction with their recombination, RecBCD should be inactivated, either by muta- cognate exonucleases carry out recombination of linear double- tion or by ␭ Gam (1, 15, 22).
    [Show full text]
  • Cre/Lox-Mediated Chromosomal Integration of Biosynthetic Gene Clusters for Heterologous Expression in Aspergillus Nidulans
    bioRxiv preprint doi: https://doi.org/10.1101/2021.08.20.457072; this version posted August 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Cre/lox-mediated chromosomal integration of biosynthetic gene clusters for heterologous expression in Aspergillus nidulans Indra Roux1, Yit-Heng Chooi1 1 School of Molecular Sciences, University of Western Australia, Perth, WA 6009, Australia. Correspondence to: [email protected] Abstract Building strains for stable long-term heterologous expression of large biosynthetic pathways in filamentous fungi is limited by the low transformation efficiency or genetic stability of current methods. Here, we developed a system for targeted chromosomal integration of large biosynthetic gene clusters in Aspergillus nidulans based on site-specific recombinase mediated cassette exchange. We built A. nidulans strains harbouring a chromosomal landing pad for Cre/lox-mediated recombination and demonstrated efficient targeted integration of a 21.5 kb heterologous region in a single step. We further evaluated the integration at two loci by analysing the expression of a fluorescent reporter and the production of a heterologous polyketide. We compared chromosomal expression at those landing loci to episomal AMA1- based expression, which also shed light on uncharacterised aspects of episomal expression in filamentous fungi.
    [Show full text]
  • Coupling Recombinase-Mediated Cassette Exchange with Somatic Hypermutation for Antibody Affinity Maturation in CHO Cells
    ARTICLE Coupling Recombinase-Mediated Cassette Exchange With Somatic Hypermutation for Antibody Affinity Maturation in CHO Cells Chuan Chen,1,2 Nan Li,1,2 Yun Zhao,1 Haiying Hang1 1 Key Laboratory for Protein and Peptide Pharmaceuticals, National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; telephone: þ86-10-64888473; fax: þ86-10-64888473; e-mail: [email protected] 2 University of Chinese Academy of Sciences, Beijing, China Introduction ABSTRACT: Heterologous expression of activation-induced cytidine deaminase (AID) can induce somatic hypermutation Technologies such as phage (de Bruin et al., 1999; Huse et al., 1992; (SHM) for genes of interest in various cells, and several research Smith, 1985; Winter et al., 1994), yeast (Boder and Wittrup, 1997; groups (including ours) have successfully improved antibody affinity in mammalian or chicken cells using AID-induced SHM. These Feldhaus et al., 2003), and bacterial displays (Francisco and affinity maturation systems are time-consuming and inefficient. In Georgiou, 1994; Mazor et al., 2009; Qiu et al., 2010) have been used this study, we developed an antibody affinity maturation platform in for antibody affinity maturation in vitro. In recent years, Chinese hamster ovary (CHO) cells by coupling recombinase- mammalian cell surface display has also been developed (Akamatsu mediated cassette exchange (RMCE) with SHM. Stable CHO cell et al., 2007; Higuchi et al., 1997; Ho et al., 2006; Wolkowicz et al., clones containing a single copy puromycin resistance gene (PuroR) expression cassette flanked by recombination target sequences (FRT 2005); it has advantages in protein folding, post-translational and loxP) being able to highly express a gene of interest placed in the modification, and code usage (Ho et al., 2006).
    [Show full text]
  • Efficient Genome Engineering by Targeted Homologous
    ARTICLE Received 14 Oct 2013 | Accepted 2 Dec 2013 | Published 13 Jan 2014 | Updated 20 Feb 2015 DOI: 10.1038/ncomms4045 Efficient genome engineering by targeted homologous recombination in mouse embryos using transcription activator-like effector nucleases Daniel Sommer1, Annika E. Peters1, Tristan Wirtz1,w, Maren Mai1, Justus Ackermann2, Yasser Thabet1, Ju¨rgen Schmidt3, Heike Weighardt4, F. Thomas Wunderlich2, Joachim Degen5, Joachim L. Schultze1 & Marc Beyer1 Generation of mouse models by introducing transgenes using homologous recombination is critical for understanding fundamental biology and pathology of human diseases. Here we investigate whether artificial transcription activator-like effector nucleases (TALENs)— powerful tools that induce DNA double-strand breaks at specific genomic locations—can be combined with a targeting vector to induce homologous recombination for the introduction of a transgene in embryonic stem cells and fertilized murine oocytes. We describe the gen- eration of a conditional mouse model using TALENs, which introduce double-strand breaks at the genomic locus of the special AT-rich sequence-binding protein-1 in combination with a large 14.4 kb targeting template vector. We report successful germline transmission of this allele and demonstrate its recombination in primary cells in the presence of Cre-recombinase. These results suggest that TALEN-assisted induction of DNA double-strand breaks can facilitate homologous recombination of complex targeting constructs directly in oocytes. 1 Genomics and Immunoregulation, LIMES Institute, University of Bonn, Carl-Troll-Strasse 31, D-53115 Bonn, Germany. 2 Max Planck Institute for Neurological Research and Institute for Genetics, University of Cologne, Gleuelerstrasse 50, D-50931 Cologne, Germany. 3 Department of Experimental Therapy, University Hospital Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany.
    [Show full text]
  • Elucidating Recombination Mediator Function Using Biophysical Tools
    biology Review Elucidating Recombination Mediator Function Using Biophysical Tools Camille Henry 1,* and Sarah S. Henrikus 2,* 1 Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA 2 Macromolecular Machines Laboratory, The Francis Crick Institute, London NW1 1AT, UK * Correspondence: [email protected] (C.H.); [email protected] (S.S.H.); Tel.: +1-608-472-3019 (C.H.) Simple Summary: This review recapitulates the initial knowledge acquired with genetics and bio- chemical experiments on Recombination mediator proteins in different domains of life. We further address how recent in vivo and in vitro biophysical tools were critical to deepen the understanding of RMPs molecular mechanisms in DNA and replication repair, and unveiled unexpected features. For instance, in bacteria, genetic and biochemical studies suggest a close proximity and coordination of action of the RecF, RecR and RecO proteins in order to ensure their RMP function, which is to over- come the single-strand binding protein (SSB) and facilitate the loading of the recombinase RecA onto ssDNA. In contrary to this expectation, using single-molecule fluorescent imaging in living cells, we showed recently that RecO and RecF do not colocalize and moreover harbor different spatiotemporal behavior relative to the replication machinery, suggesting distinct functions. Finally, we address how new biophysics tools could be used to answer outstanding questions about RMP function. Abstract: The recombination mediator proteins (RMPs) are ubiquitous and play a crucial role in genome stability. RMPs facilitate the loading of recombinases like RecA onto single-stranded (ss) DNA coated by single-strand binding proteins like SSB. Despite sharing a common function, RMPs are the products of a convergent evolution and differ in (1) structure, (2) interaction partners and (3) Citation: Henry, C.; Henrikus, S.S.
    [Show full text]
  • The RAG Recombinase: Beyond Breaking. Chloé Lescale, Ludovic Deriano
    The RAG recombinase: Beyond breaking. Chloé Lescale, Ludovic Deriano To cite this version: Chloé Lescale, Ludovic Deriano. The RAG recombinase: Beyond breaking.. Mechanisms of Ageing and Development, Elsevier, 2016, 10.1016/j.mad.2016.11.003. pasteur-01416603 HAL Id: pasteur-01416603 https://hal-pasteur.archives-ouvertes.fr/pasteur-01416603 Submitted on 21 Feb 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives| 4.0 International License The RAG recombinase: Beyond breaking Chlo´eLescale, Ludovic Deriano To cite this version: Chlo´eLescale, Ludovic Deriano. The RAG recombinase: Beyond breaking. Mechanisms of Ageing and Development, Elsevier, 2016, <10.1016/j.mad.2016.11.003>. <pasteur-01416603> HAL Id: pasteur-01416603 https://hal-pasteur.archives-ouvertes.fr/pasteur-01416603 Submitted on 15 Dec 2016 HAL is a multi-disciplinary open access L'archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destin´eeau d´ep^otet `ala diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publi´esou non, lished or not. The documents may come from ´emanant des ´etablissements d'enseignement et de teaching and research institutions in France or recherche fran¸caisou ´etrangers,des laboratoires abroad, or from public or private research centers.
    [Show full text]
  • Recent Advances in Gene Mutagenesis by Site-Directed Recombination
    Recent advances in gene mutagenesis by site-directed recombination. J D Marth J Clin Invest. 1996;97(9):1999-2002. https://doi.org/10.1172/JCI118634. Perspective Find the latest version: https://jci.me/118634/pdf Perspectives Series: Molecular Medicine in Genetically Engineered Animals Recent Advances in Gene Mutagenesis by Site-directed Recombination Jamey D. Marth Howard Hughes Medical Institute, Department of Medicine and Division of Cellular and Molecular Medicine, University of California San Diego, La Jolla, California 92093 Transgenic experimentation yields insights that could not be lack of cell or tissue development may result from ES cell perceived otherwise among populations of mammalian organ- clonal variation, use of multiple ES clones and complementa- isms (reviewed in references 1 and 2). However, information tion by gene transfer allow for controlled studies. Some con- gained may, on occasion, be somewhat limited should germ- siderations remain the inability to direct genetic variation to line gene dysfunction be deleterious in embryonic develop- multiple, experimentally defined cell lineages and the poten- ment, thereby precluding analyses in various somatic compart- tially unique nature of each chimeric mouse generated. ments of the adult organism. The production of chimeric mice Since inception, gene transfer experimentation has been bearing genetic mutations specifically in various somatic cells generally limited to irreversible modifications of chromosomal allows the study of gene function in physiologic contexts that DNA. Isolation of cells having undergone site-specific ex- would otherwise be unavailable or lethal. One elegant cell change or deletion of DNA sequence has only recently been type-restricted chimeric approach has been the use of the developed using novel screening strategies for often low fre- RAG 2-null embryos as recipients in gene-targeted embryonic quency events.
    [Show full text]
  • Mechanism of Homologous Recombination: Mediators and Helicases Take on Regulatory Functions
    REVIEWS Mechanism of homologous recombination: mediators and helicases take on regulatory functions Patrick Sung* and Hannah Klein‡ Abstract | Homologous recombination (HR) is an important mechanism for the repair of damaged chromosomes, for preventing the demise of damaged replication forks, and for several other aspects of chromosome maintenance. As such, HR is indispensable for genome integrity, but it must be regulated to avoid deleterious events. Mutations in the tumour- suppressor protein BRCA2, which has a mediator function in HR, lead to cancer formation. DNA helicases, such as Bloom’s syndrome protein (BLM), regulate HR at several levels, in attenuating unwanted HR events and in determining the outcome of HR. Defects in BLM are also associated with the cancer phenotype. The past several years have witnessed dramatic advances in our understanding of the mechanism and regulation of HR. Homologous recombination (HR) occurs in all life homologous chromosomes and generates chromosome- Meiosis I The successful completion of forms. HR studies were initially the domain of a few arm crossovers. These crossovers are essential for proper meiosis requires two cell aficionados who had a desire to understand how genetic chromosome segregation at the first meiotic division2,4. divisions. Meiosis I refers to the information is transferred and exchanged between Mitotic HR differs from meiotic HR in that few events are first division in which the pairs chromosomes. The isolation and characterization of associated with crossover and indeed, crossover formation of homologous chromosomes 1 DNA helicases are segregated into the two relevant mutants in Escherichia coli , and later in the is actively suppressed by specialized (see daughter cells.
    [Show full text]
  • The Cre Recombinase Gene Y
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 3932-3936, April 1996 Neurobiology Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene Y. WANG*, L. A. KRUSHEL*t, AND G. M. EDELMAN*t *Department of Neurobiology, The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037; and tThe Neurosciences Institute, 10640 John Jay Hopkins Road, San Diego, CA 92121 Contributed by G. M. Edelman, December 26, 1995 ABSTRACT Conditional gene expression and gene dele- sequences, each of which is 34 bp in length (7, 8). The tion are important experimental approaches for examining intramolecular recombination of two loxP sites (oriented ei- the functions of particular gene products in development and ther head-to-head or head-to-tail) results in an inversion or disease. The cre-loxP system from bacteriophage P1 has been deletion of the intervening DNA sequences, and an intermo- used in transgenic animals to induce site-specific DNA re- lecular recombination causes integration or reciprocal trans- combination leading to gene activation or deletion. To regulate location at the loxP site. The cre-loxP system has been tested the recombination in a spatiotemporally controlled manner, in various eukaryotic organisms and shown to function effi- we constructed a recombinant adenoviral vector, Adv/cre, that ciently in mammalian cells (9-13). It has been used in trans- contained the cre recombinase gene under regulation of the genic animals to achieve conditional gene activation or dele- herpes simplex virus thymidine kinase promoter. The efficacy tion (knockout) of targeted genes in specific tissues (5, 6, 14).
    [Show full text]
  • Requirements for Catalysis in Cre Recombinase
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations Summer 2010 Requirements for Catalysis in Cre Recombinase Bryan P S Gibb Biochemistry and Molecular Biophysics, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biochemistry, Biophysics, and Structural Biology Commons Recommended Citation Gibb, Bryan P S, "Requirements for Catalysis in Cre Recombinase" (2010). Publicly Accessible Penn Dissertations. 427. https://repository.upenn.edu/edissertations/427 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/427 For more information, please contact [email protected]. Requirements for Catalysis in Cre Recombinase Abstract Cre recombinase, a member of the tyrosine recombinase (YR) family of site-specific ecombinasesr catalyzes DNA rearrangements using phosphoryl transfer chemistry that is identical to that used by the type IB topoisomerases (TopIBs). In this dissertation, the requirements for YR catalysis and the relationship between the YRs and the TopIBs are explored. I have analyzed the in vivo and in vitro recombination activities of all possible substitutions of the seven active site residues in Cre recombinase. To facilitate the interpretation mutant activities, I also determined the structure of a vanadate transition state mimic for the Cre-loxP reaction that allows for a comparison with similar structures from the related TopIBs. The results demonstrate that active site residues shared by the TopIBs are most sensitive to substitution. Two of the conserved active site residues in YRs have no equivalent in TopIBs. I have concluded that Glu176 and His289 in Cre evolved to have functional roles in site-specific ecombination,r that are unnecessary for relaxation by TopIB.
    [Show full text]